IMGN-779 shows a significant medicinal approach within relapsed/refractory AML arena. This first-in-class naked protein selectively recognizes CD33, the protein found on nearly all immature myeloid cells. Unlike https://www.targetmol.com/compound/anti_cd33_antibody__imgn_779_naked_antibody_